Breaking News, Collaborations & Alliances

Immunologix, DavosPharma In Antibody Pact

Immunologix and DavosPharma have formed a strategic alliance under which DavosPharma will represent and market human antibodies produced by Immunologix.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Immunologix and DavosPharma have formed a strategic alliance under which DavosPharma will represent and market human antibodies produced by Immunologix. Immunologix specializes in transforming naïve B-cells to produce 100% human monoclonal antibodies that can target all antigens including, cancer, viruses, bacteria, toxins and autoimmune diseases like diabetes, lupus, rheumatoid arthritis and multiple sclerosis. DavosPharma evaluates, coordinates and delivers chemistry through strategic partners...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters